Empyrean Technology (301269) H2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2024 earnings summary
18 Dec, 2025Executive summary
Revenue reached ¥1.22 billion in 2024, up 20.98% year-over-year, setting a new record.
Net profit attributable to shareholders was ¥109.48 million, down 45.46% year-over-year.
Gross margin remained high at 93.31%, with EDA software sales as the main revenue driver.
R&D investment hit ¥868.12 million, accounting for 71.02% of revenue.
The company maintained its position as the leading domestic EDA provider, serving nearly 700 clients.
Financial highlights
Operating cash flow was negative at -¥51.78 million, a sharp decline from ¥248.52 million in 2023.
Total assets at year-end were ¥5.63 billion, up 1.69% from the previous year.
Net assets attributable to shareholders rose 4.62% to ¥5.00 billion.
Basic and diluted EPS were both ¥0.20, down 45.95% year-over-year.
Non-recurring gains (mainly asset disposals and government grants) totaled ¥166.55 million.
Outlook and guidance
Focus on strengthening R&D, especially in 3DIC, digital simulation, and advanced process EDA tools.
Plans to expand market share domestically and globally, leveraging strong client relationships.
Emphasis on talent development and industry-academia collaboration to build a robust technical team.
Continued investment in product innovation and ecosystem expansion to maintain competitive edge.
Latest events from Empyrean Technology
- Revenue up, profit down sharply as costs rise; cash flow strong, subsidies key.301269
Q3 202530 Oct 2025 - Revenue up 13%, net profit down 91.9% on high R&D; new EDA tools and strong overseas growth.301269
H1 202520 Aug 2025 - Revenue up, profit down sharply as costs rise and new EDA products launch.301269
Q3 202413 Jun 2025 - Revenue up 9.6% but net profit down 54.8% as R&D investment hits 78.7% of sales.301269
H1 202413 Jun 2025 - Revenue and net profit grew strongly in Q1 2025, supported by robust cash flow and policy subsidies.301269
Q1 20256 Jun 2025